Kristian Løvvik Juul-Dam

7PUBLICATIONS
19CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursNeonatologyPaediatrics not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.

|May 18, 2026
Deep Sequencing of FLT3-ITD Enables Response Evaluation and Post-Treatment Monitoring in Childhood AML: An Exploratory Study.

|Aug 19, 2025
Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML study.

Morten Krogh Herlin, Eigil Kjeldsen, Jonas Abrahamsson

|Nov 04, 2022
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.

Anne Sofie Borg Hammer, Kristian Løvvik Juul-Dam, Julie Damgaard Sandahl

|Apr 14, 2021
Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse.

Anne-Sofie Skou, Kristian Løvvik Juul-Dam, Hans B Ommen

|Mar 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.

Kristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold

Pageof 2

Frequent Collaborators

2 joint publications

Bernward Zeller

2 joint publications

Henrik Hasle

1 joint publications

Anne-Sofie Skou

1 joint publications

Anne Sofie Borg Hammer